Uchechukwu C Megwalu, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Megwalu’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A138984 · Current
Licensed to practise in California · since 2015 · expires 2028-12-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$44,318
Medicare paid this office $44,318 for 211 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 36 | $3,427 | $95 |
| New patient visit (30+ min) | 54 | $3,358 | $62 |
| Short return visit (20+ min) | 50 | $3,094 | $53 |
| Return visit (30+ min) | 36 | $2,931 | $75 |
| Diagnostic exam of voice box using a flexible endoscope | 33 | $2,192 | $56 |
See all 10 services
| New patient visit (45+ min) | 36 | $3,427 | $95 |
| New patient visit (30+ min) | 54 | $3,358 | $62 |
| Short return visit (20+ min) | 50 | $3,094 | $53 |
| Return visit (30+ min) | 36 | $2,931 | $75 |
| Diagnostic exam of voice box using a flexible endoscope | 33 | $2,192 | $56 |
| Long return visit (40+ min) | 11 | $1,563 | $130 |
| Return visit (30+ min) | 11 | $1,487 | $124 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $1,228 | $58 |
| Short return visit (20+ min) | 12 | $1,151 | $89 |
| Removal of impacted ear wax | 35 | $765 | $21 |
Who their Medicare patients are
211 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 8% · Women 56% · Also on Medicaid 36% · Health risk score 1.47. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 62% · Diabetes 23% · Coronary heart disease 23% · Chronic kidney disease 23% · Cancer 17% · Atrial fibrillation 16% · COPD 14% · Depression 13% · Heart failure 10% · Stroke 5%.
The office billed $220,858, Medicare allowed $60,278 and paid $44,318; for 460 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 211 | 460 | 73 | 1.47 | $220,858 | $44,318 |
| 2023 | 188 | 432 | 72 | 1.47 | $196,832 | $41,020 |
| 2022 | 248 | 569 | 72 | 1.29 | $213,377 | $53,367 |
| 2021 | 217 | 491 | 72 | 1.48 | $231,764 | $52,781 |
| 2020 | 162 | 350 | 71 | 1.51 | $99,804 | $25,757 |
| 2019 | 224 | 553 | 71 | 1.76 | $134,378 | $38,138 |
| 2018 | 182 | 467 | 72 | 1.54 | $154,142 | $38,459 |
| 2017 | 190 | 484 | 71 | 1.60 | $201,913 | $37,244 |
| 2016 | 170 | 423 | 70 | 1.33 | $143,887 | $32,791 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| New patient visit (45+ min) | 57 | $5,929 | $104 |
| Return visit (30+ min) | 47 | $4,144 | $81 |
| Short return visit (20+ min) | 44 | $2,902 | $55 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $2,699 | $59 |
| New patient visit (30+ min) | 38 | $2,343 | $62 |
| Long return visit (40+ min) | 12 | $1,729 | $133 |
| Diagnostic exam of nasal passages using an endoscope | 37 | $1,273 | $30 |
| Removal of impacted ear wax | 22 | $567 | $23 |
| Short return visit | 11 | $327 | $30 |
2022: 11 services
| New patient visit (45+ min) | 81 | $9,398 | $116 |
| Return visit (30+ min) | 59 | $6,559 | $87 |
| Long return visit (40+ min) | 28 | $3,615 | $117 |
| Diagnostic exam of voice box using a flexible endoscope | 56 | $3,614 | $58 |
| New patient visit (60+ min) | 16 | $2,687 | $168 |
| Short return visit (20+ min) | 47 | $2,656 | $52 |
| New patient visit (30+ min) | 33 | $1,995 | $60 |
| Removal of impacted ear wax | 46 | $1,313 | $25 |
| Diagnostic exam of nasal passages using an endoscope | 34 | $1,130 | $26 |
| Short return visit | 15 | $496 | $29 |
| Exam of ear using a microscope | 15 | $138 | $8 |
2021: 10 services
| New patient visit (45+ min) | 77 | $9,172 | $119 |
| Return visit (30+ min) | 49 | $5,443 | $89 |
| Long return visit (40+ min) | 29 | $3,536 | $118 |
| Short return visit (20+ min) | 48 | $2,926 | $54 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $2,420 | $56 |
| New patient visit (30+ min) | 34 | $2,224 | $65 |
| Removal of impacted ear wax | 33 | $853 | $25 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $655 | $23 |
| Short return visit | 19 | $464 | $24 |
| Exam of ear using a microscope | 12 | $141 | $9 |
2020: 7 services
| New patient visit (30+ min) | 68 | $3,948 | $58 |
| Return visit (30+ min) | 40 | $2,760 | $64 |
| Short return visit (20+ min) | 47 | $2,526 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 28 | $1,730 | $58 |
| New patient visit (15+ min) | 20 | $890 | $44 |
| Removal of impacted ear wax | 23 | $594 | $23 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $374 | $16 |
2019: 8 services
| New patient visit (30+ min) | 133 | $8,253 | $62 |
| Return visit (30+ min) | 66 | $5,383 | $68 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $4,195 | $59 |
| Short return visit (20+ min) | 69 | $3,343 | $43 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $1,852 | $39 |
| Removal of impacted ear wax | 36 | $850 | $21 |
| Short return visit | 15 | $379 | $21 |
| Exam of ear using a microscope | 17 | $176 | $9 |
2018: 7 services
| New patient visit (30+ min) | 120 | $7,489 | $62 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $3,424 | $60 |
| Short return visit (20+ min) | 56 | $3,351 | $45 |
| Return visit (30+ min) | 39 | $3,267 | $68 |
| Diagnostic exam of nasal passages using an endoscope | 33 | $1,767 | $50 |
| Removal of impacted ear wax | 27 | $660 | $24 |
| Ultrasound scan of head and neck soft tissue | 15 | $357 | $24 |
2017: 6 services
| New patient visit (30+ min) | 120 | $7,632 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 81 | $5,512 | $58 |
| Short return visit (20+ min) | 68 | $3,480 | $39 |
| Return visit (30+ min) | 42 | $3,386 | $66 |
| Diagnostic exam of nasal passages using an endoscope | 41 | $2,340 | $53 |
| Removal of impacted ear wax | 27 | $601 | $22 |
2016: 7 services
| New patient visit (30+ min) | 94 | $6,305 | $67 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $5,645 | $71 |
| Return visit (30+ min) | 52 | $3,593 | $65 |
| Short return visit (20+ min) | 44 | $2,415 | $46 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $2,251 | $52 |
| New patient visit (45+ min) | 11 | $1,089 | $99 |
| Removal of impacted ear wax | 26 | $585 | $20 |
Medicaid work
$1,978 in 2024
Medicaid paid $1,978 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 13 | $1,569 |
| Short return visit (20+ min) | 12 | $409 |
| 2024 | 25 | 2 | 13 | $1,978 |
| 2023 | 38 | 3 | 13 | $2,143 |
| 2022 | 112 | 4 | 16 | $6,402 |
| 2021 | 126 | 3 | 16 | $8,242 |
| 2020 | 71 | 1 | 17 | $5,719 |
| 2019 | 120 | 1 | 20 | $9,194 |
| 2018 | 93 | 1 | 18 | $6,958 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 12 | $787 |
| New patient visit (30+ min) | 13 | $779 |
| Return visit (30+ min) | 13 | $577 |
2022
| New patient visit (45+ min) | 69 | $4,884 |
| Return visit (30+ min) | 16 | $797 |
| Service | 15 | $546 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $174 |
2021
| New patient visit (45+ min) | 69 | $5,996 |
| Return visit (30+ min) | 31 | $1,225 |
| Service | 26 | $1,021 |
2020
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 71 | $5,719 |
2019
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 120 | $9,194 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 93 | $6,958 |
Drugs they prescribed that Part D paid
$1,102
Pharmacies billed $1,102 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
76 generic and fewer than 11 brand-name prescriptions · $1,102 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 30 | $275 | $9 |
| Azelastine | 18 | $254 | $14 |
Year by year
| 2024 | 77 | 35 | None | None | $1,102 |
| 2023 | 49 | 29 | 0% (0) | 0% | $990 |
| 2022 | 79 | 40 | 0% (0) | None | $3,403 |
| 2021 | 40 | 23 | 0% (0) | None | $2,623 |
| 2020 | 51 | 22 | None | None | $1,352 |
| 2019 | 41 | 27 | None | None | $1,899 |
| 2018 | 104 | 42 | None | None | $3,301 |
| 2017 | 102 | 39 | None | None | $2,690 |
| 2016 | 90 | 38 | None | 19% | $4,562 |
| 2015 | 221 | 61 | 5% (11) | 23% | $21,520 |
| 2014 | 190 | 71 | 7% (14) | 34% | $20,979 |
| 2013 | 245 | 81 | None | 21% | $18,620 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Azelastine | 15 | $405 | $27 |
| Fluticasone Propionate | 18 | $275 | $15 |
2022: 2 drugs
| Azelastine | 12 | $759 | $63 |
| Fluticasone Propionate | 29 | $466 | $16 |
2020: 1 drug
| Omeprazole | 13 | $72 | $6 |
2018: 2 drugs
| Azelastine | 16 | $844 | $53 |
| Fluticasone Propionate | 36 | $494 | $14 |
2017: 2 drugs
| Azelastine | 17 | $749 | $44 |
| Fluticasone Propionate | 44 | $538 | $12 |
2016: 2 drugs
| Fluticasone Propionate | 30 | $345 | $12 |
| Omeprazole | 16 | $217 | $14 |
2015: 2 drugs
| Nexium | 47 | $15,474 | $329 |
| Fluticasone Propionate | 109 | $1,288 | $12 |
2014: 4 drugs
| Nexium | 41 | $14,486 | $353 |
| Nasonex | 11 | $1,822 | $166 |
| Fluticasone Propionate | 64 | $1,346 | $21 |
| Ofloxacin | 11 | $304 | $28 |
2013: 6 drugs
| Nexium | 29 | $10,347 | $357 |
| Fluticasone Propionate | 76 | $2,377 | $31 |
| Nasonex | 15 | $2,208 | $147 |
| Fluocinolone Acetonide Oil | 23 | $1,011 | $44 |
| Omeprazole | 24 | $477 | $20 |
| Ofloxacin | 11 | $175 | $16 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1730370941
- Licence
- CA A138984California A138984: Current · expires 2028-12-31
- Trained
- Washington University School of Medicine, 2006
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 801 Welch Rd Dept of, Palo Alto, CA, 94304
- NPI first listed
- 2007-08-05
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.